HEALTHEQUITY INC (HQY) Stock Analyst Ratings
USA - NASDAQ:HQY - US42226A1079 - Common Stock
98.81 USD
-1.02 (-1.02%)
ChartMill assigns a Buy % Consensus number of 86% to HQY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 123.89. This target is 25.38% above the current price.
HQY was analyzed by 18 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about HQY.
In the previous month the buy percentage consensus was at a similar level.
HQY was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-09-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-09-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-03 | Jefferies | Maintains | Buy -> Buy |
| 2025-08-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-08 | Raymond James | Reiterate | Strong Buy -> Strong Buy |
| 2025-06-05 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-06-05 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-06-04 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-06-04 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-16 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-04-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-27 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-25 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2025-03-24 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-03-19 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-25 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-12-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-12-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-12-04 | Mizuho | Initiate | Outperform |
| 2024-12-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-15 | Goldman Sachs | Initiate | Neutral |
| 2024-11-14 | BTIG | Maintains | Buy -> Buy |
| 2024-11-13 | B of A Securities | Maintains | Buy -> Buy |
HEALTHEQUITY INC / HQY FAQ
What is the price target for HQY stock?
18 analysts have analysed HQY and the average price target is 123.89 USD. This implies a price increase of 25.38% is expected in the next year compared to the current price of 98.81.
How do analysts rate HEALTHEQUITY INC (HQY)?
The consensus rating for HEALTHEQUITY INC (HQY) is 85.5556 / 100 . This indicates that analysts generally have a positive outlook on the stock.